ExPEC10V

N/A

Report date: 2024/06/27 20:00:09

Base Information

Drug NameExPEC10V
Drug Alias NameEscherichia coli bioconjugate vaccine - JanssenE. coli vaccine - JanssenVAC-52416
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEscherichia coli Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesJanssen Pharmaceutical Kk
Active IndicationsEscherichia coli Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A